Strides Pharma Science informs about press release

22 Dec 2022 Evaluate
Strides Pharma Science has informed that it enclosed press release ‘Receipt of AUD 94 million on account of deferred consideration on the sale of the Company’s Australian operations in 2019’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×